Abbott India said that it has signed a non-exclusive patent license agreement with Takeda Pharmaceuticals Company to commercialize Vonoprazan, a novel molecule in the gastrointestinal therapy area, ...

The gold standard for diagnosing gastroesophageal reflux disease (GERD) is impedance-pH monitoring. This test is particularly ...

Caroline Cobine, Ph.D., an associate professor in the Department of Physiology and Cell Biology within the University of ...

Approximately 600 times a day, the esophagus ferries whatever is in your mouth down to your stomach. It's usually a one-way ...

The following is a summary of “Gastrointestinal dysmotility is associated with proton pump inhibitor refractory esophagitis in patients with systemic sclerosis,” published in the September 2024 issue ...

Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...

People with a history of upper gastrointestinal (GI) damage have a 76% higher risk of developing Parkinson’s disease.

Over a mean follow-up of 14.9 years, Parkinson's diagnoses emerged for 52 patients (2.2%) with upper GI mucosal damage and 48 ...

There are times when the stomach acid goes right into the esophagus, and causes symptoms like heartburn. Acid reflux, especially while sleeping, is common among people living with the chronic ...

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson's disease ...